Therapy: Assessing cancer risk of cytokine inhibitors in RA.
Strangfeld
Anja
A
Zink
Angela
A
D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000453:epidemiology; D002648:Child; D015897:Comorbidity; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009369:Neoplasms / Q000453:epidemiology / Q000209:etiology*; D018570:Risk Assessment; D012307:Risk Factors; D013548:Sweden / Q000453:epidemiology
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents